"ABBV expects Japan to approve V-Pak during 4Q15." I think ABBV already gained V-Pak approval in Japan near the end of 3Q15: http://www.fiercepharmaasia.com/story/abbvie-wins-viekirax-nod-japan-expected-competition-seen-tight/2015-09-29 http://abbvie.mediaroom.com/2015-09-28-AbbVies-VIEKIRAX-ombitasvir-paritaprevir-ritonavir-tablets-Receives-Approval-in-Japan-for-the-Treatment-of-Genotype-1-Chronic-Hepatitis-C